FIVE PRIME THERAPEUTICS INC 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 3, 2016
Insider Transaction Report
Form 4
Baker Kevin Paul
SVP, Development Sciences
Transactions
- Award
Common Stock
2016-02-01+75,000→ 75,000 total - Award
Employee Stock Option (right to buy)
2016-02-01+75,000→ 75,000 totalExercise: $35.53Exp: 2026-01-31→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: 50% of the restricted stock vests on February 1, 2018 with the remainder vesting on February 1, 2019, provided the reporting person remains employed by Five Prime Therapeutics, Inc. ("the Company") through each such date.
- [F2]One-fourth (1/4th) of the shares underlying the option will vest on February 1, 2017, and the remainder of the shares underlying the option vest at a rate of one forty-eighth (1/48th) per month thereafter, provided the reporting person remains employed by the Company through each such date.